Bruno Wohlschlegel

Managing Director
Pharma
Merck
Portugal

Business Expert Pharmaceutical Sciences
Biography

Spezialgebiete: Oncology Neurology Development of growth strategies Competitive positioning Biomarker guided market strategies Marketing - sales communication Organizational turnaround Change management.Head of late stage products incl. Erbitux (EGFR-antibody) Stimuvax (Immunotherapy, phase III), cilengitide (Integrininhibitor, phase III) Strategy development Launchplanning Brand development and positionning HQ/affiliate interface Leadership.

Research Intrest

Business developement

Global Scientific Words in Pharmaceutical Sciences